Stay updated with breaking news from Pathalys Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
State budget negotiators are weighing $1.4 billion for NCInnovation, a private, non-profit aimed at providing grants to commercialize university or research.
The Senate budget proposal allocates $1.425 billion to NCInnovation, a non-profit aimed at fostering innovation and economic growth in the state.
Cancer continues to be a hot area of investment, and it’s the therapeutic focus of several biotech companies that have closed recent rounds of financing. Meanwhile, the investment arm of a big pharmaceutical company has an infusion of new cash to deploy in therapeutic and digital investments.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Sebetralstat Phase 3 KONFIDENT and KVD824 Phase 2 KOMPLETE Clinical Trial Enrollment on Track - Formal Notification Received of Sebetralstat EU Orphan Drug Status - KalVista Pharmaceuticals, Inc.